Veracyte (VCYT) Says New Study Published in JAMA Surgery Demonstrates Afirma GSC's Ability to Significantly Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis
Tweet Send to a Friend
Veracyte, Inc. (Nasdaq: VCYT) announced that clinical validation data published for the first time today – in JAMA Surgery – ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
